# Test of the Efficacy and Safety of Insulin Glulisine Injected Subcutaneously in Patients With Type 1 Diabetes Mellitus

> **NCT00964574** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 68 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** INSULIN GLULISINE (HMR1964)
- **DRUG:** INSULIN GLARGINE

## Key facts

- **NCT ID:** NCT00964574
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2012-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00964574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00964574, "Test of the Efficacy and Safety of Insulin Glulisine Injected Subcutaneously in Patients With Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00964574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*